Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Aurobindo Pharma Ltd

NSE :AUROPHARMA   BSE :524804  Sector : Pharmaceuticals
Buy, Sell or Hold AUROPHARMA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

19 Nov
1250.10
(1.19%)
18 Nov
1235.40
(-1.09%)
14 Nov
1249.00
(-0.04%)
13 Nov
1249.45
(-1.42%)
12 Nov
1267.40
(-1.68%)
11 Nov
1289.05
(-2.90%)
08 Nov
1327.55
(-1.71%)
07 Nov
1350.60
(-3.17%)
06 Nov
1394.85
(-0.15%)
05 Nov
1396.95
(-0.73%)
04 Nov
1407.20
(0.46%)
01 Nov
1400.70
(0.30%)
31 Oct
1396.50
(-0.62%)
30 Oct
1405.15
(-0.51%)
29 Oct
1412.35
(-1.55%)
28 Oct
1434.55
(0.45%)
25 Oct
1428.15
(-0.97%)
24 Oct
1442.20
(0.57%)
23 Oct
1434.00
(-0.94%)
22 Oct
1447.60
(-0.87%)
21 Oct
1460.25
(-0.85%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Neutral

Moving Averages

5 DMA
Bearish

1249.63

10 DMA
Bearish

1300.48

20 DMA
Bearish

1360.54

50 DMA
Bearish

1443.99

100 DMA
Bearish

1431.3

200 DMA
Bearish

1274.76


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 19, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1302.91 1285.13 1259.81 - -
R2 1285.13 1271.65 1256.57 1285.2 -
R1 1267.61 1263.31 1253.34 1267.75 1276.38
P 1249.83 1249.83 1249.83 1249.9 1254.21
S1 1232.31 1236.35 1246.86 1232.45 1241.08
S2 1214.53 1228.01 1243.63 1214.6 -
S3 1197.01 1214.53 1240.39 - -

Key Metrics

EPS

35.31

P/E

35.34

P/B

3.72

Dividend Yield

0.36%

Market Cap

73,248 Cr.

Face Value

1

Book Value

335.47

ROE

11.18%

EBITDA Growth

1,701.44 Cr.

Debt/Equity

0.21

Shareholding Pattern

  51.82% Total Promoter Holding
18.53% Mutual Fund Holdings
16.59% FIIs
6.46% Non Institution
4.66% Insurance Companies
0% Custodians
1.94% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Aurobindo Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 7407.3 7514.3 7715.77 7787.95 7932.37
PROFIT 757.18 936.29 974.2 919.22 817.38
EPS 12.83 16.04 15.51 15.69 14

Aurobindo Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 2771.93 3023.16 3017 2525.41 2947.25
PROFIT 379.65 623.78 578.67 329.04 537.53
EPS 7.1 10.65 9.88 5.62 9.21

Profit & Loss (Figures in Rs. Crores)


Aurobindo Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 12546.71 14092.78 15339.65 17050.67 20397.12 23392.24 29135.18 23075.19 25555.65 30505.42
PROFIT 1587.14 2028.78 2306.24 2423.17 2430.63 2864.68 3410.14 2757.17 1919.7 3272.95
EPS 26.48 34.58 38.88 41.35 40.36 48.54 91.04 45.18 32.9 54.09

Aurobindo Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 8321.41 9496.13 9711.68 10684.73 12746.91 13998.23 16410.55 11912.62 9164.87 11431.97
PROFIT 1518.29 1627.51 1720.3 1812.82 1537.74 1878.78 3113.04 1535.98 1217.17 1952.97
EPS 25.54 27.8 28.73 30.94 26.11 32.03 53.13 24.83 20.94 33.35

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 58.5958.5958.5958.5958.5958.5958.5958.5958.5229.2
Reserves Total 29,784.2126,781.2624,517.3921,871.2816,766.0813,832.1911,621.839,313.327,228.785,126.71
Total Shareholders Funds29,842.826,839.8524,575.9821,929.8716,824.6713,890.7811,680.429,371.917,287.35,155.91
Minority Interest812-1.93-0.880.141.591.822.082.5525.82
Secured Loans 3,968.372,557.37543.691,053.551,314.971,661.87419.18640.82,285.152,081.94
Unsecured Loans 2,679.262,728.842,307.584,285.534,511.415,304.894,350.752,723.342,755.922,369.13
Total Debt6,647.635,286.212,851.275,339.085,826.386,966.764,769.933,364.145,041.074,451.07
Other Liabilities277.59214.26212.91250.71162.1980.1666.4339.1323.3624.35
Total Liabilities36,776.0232,352.3227,638.2327,518.7822,813.3820,939.2916,518.612,777.2612,354.289,657.15
APPLICATION OF FUNDS :
Gross Block 23,447.7718,593.3215,524.5513,613.3312,441.2610,497.627,894.785,635.494,569.835,446.13
Less: Accumulated Depreciation8,954.987,569.634,992.464,239.753,044.792,022.771,374.1801.71390.141,740.49
Net Block14,492.7911,023.6910,532.099,373.589,396.478,474.856,520.684,833.784,179.693,705.64
Capital Work in Progress3,868.725,390.013,747.23,061.531,985.921,668.461,583.041,458.08848.14419.63
Investments 372.23542.74997.15591.01554.71360.22311.54245.87122.9619.79
Inventories 9,810.478,516.117,559.089,041.187,699.877,245.65,858.414,330.544,056.143,611.3
Sundry Debtors 4,816.744,466.384,012.263,503.284,315.163,413.783,080.22,765.334,606.683,539.17
Cash and Bank Balance6,278.36,084.24,190.015,474.282,842.151,957.181,262.25513.48800.26469.11
Loans and Advances 2,818.072,247.11,987.721,659.591,555.312,715.721,977.281,596.81831.25659.57
Total Current Assets23,723.5821,313.7917,749.0719,678.3316,412.4915,332.2812,178.149,206.1610,294.338,279.15
Current Liabilities 7,433.136,735.935,643.945,378.375,310.954,849.094,052.933,161.53,409.032,828.56
Provisions 508.04417.01233.82396.89511.72384.67294.23261.36132.93218.24
Total Current Liabilities & Provisions7,941.177,152.945,877.765,775.265,822.675,233.764,347.163,422.863,541.963,046.8
Net Current Assets15,782.4114,160.8511,871.3113,903.0710,589.8210,098.527,830.985,783.36,752.375,232.35
Deferred Tax Assets1,335.71768.88429.74600.91163.2183.29539.17501.82227.3733.3
Deferred Tax Liability479.63481552.11722.79291.69281.31615.65383.3645.05239.08
Net Deferred Tax856.08287.88-122.37-121.88-128.49-98.02-76.48118.46182.32-205.78
Other Assets1,403.79947.15612.85711.47414.95435.26348.84337.77268.8485.52
Total Assets36,776.0232,352.3227,638.2327,518.7822,813.3820,939.2916,518.612,777.2612,354.289,657.15
Contingent Liabilities311.34158.53157.74140.83145.98133.71211.79196.97177.11195.38
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 58.5958.5958.5958.5958.5958.5958.5958.5958.5229.2
Reserves Total 19,664.2317,975.4417,058.7515,866.0212,993.9111,292.039,923.998,377.596,807.335,330.34
Total Shareholders Funds19,722.8218,034.0317,117.3415,924.6113,052.511,350.629,982.588,436.186,865.855,359.54
Secured Loans 1,431.991,922.78288.75841.51,314.361,594.43376.19498.651,002.711,884.01
Unsecured Loans 1,428.752,280.381,606.143,200.462,427.12,925.373,342.812,555.263,162.721,400.72
Total Debt2,860.744,203.161,894.894,041.963,741.464,519.83,7193,053.914,165.433,284.73
Other Liabilities4687.315.03042.6822.6433.620.8721.2622.65
Total Liabilities22,629.5622,324.519,017.2619,966.5716,836.6415,893.0613,735.1811,510.9611,052.548,666.92
APPLICATION OF FUNDS :
Gross Block 4,043.496,214.715,724.96,688.96,180.915,446.154,292.183,758.182,830.783,507.54
Less : Accumulated Depreciation 1,624.362,527.212,139.072,216.831,763.111,296.45899.21546.56262.651,317.53
Net Block 2,419.133,687.53,585.834,472.074,417.84,149.73,392.973,211.622,568.132,190.01
Capital Work in Progress132.68239.09225.15734.89814.85789.011,143.98906.98742.14227.19
Investments 13,393.448,105.376,584.365,009.932,527.412,339.061,967.51,681.951,183.351,012.75
Inventories 2,367.64,125.263,356.184,841.384,359.573,971.263,409.232,433.622,431.62,145.05
Sundry Debtors 3,776.594,560.263,973.245,928.015,7855,232.074,468.233,773.634,380.973,708.94
Cash and Bank Balance94.34373.4150.78386.1886.1675.77245.933.64330.8111.13
Loans and Advances 1,000.59906.052,454.91,051.41,057.551,129.22857.82662.44631.1483.32
Total Current Assets7,239.129,964.989,835.112,206.9711,288.2810,408.328,981.186,903.337,774.486,348.44
Current Liabilities 2,285.862,396.312,243.32,539.032,526.662,120.151,960.641,450.461,456.071,262.6
Provisions 119.65122.09103.36250.01115.2796.5174.5461.556.9586.02
Total Current Liabilities & Provisions2,405.512,518.42,346.662,789.042,641.932,216.662,035.181,511.961,513.021,348.62
Net Current Assets4,833.617,446.587,488.449,417.938,646.358,191.666,9465,391.376,261.464,999.82
Deferred Tax Assets47.4555.2443.8268.61411.92439.87382.06333.52267.9728.55
Deferred Tax Liability166.36271.15280.85501.99496.96470.87405.54333.44261.11238.89
Net Deferred Tax-118.91-215.91-237.03-433.38-85.04-31-23.480.086.86-210.34
Other Assets1,969.613,061.871,370.51765.13515.27454.63308.21318.96290.6447.49
Total Assets22,629.5622,324.519,017.2619,966.5716,836.6415,893.0613,735.1811,510.9611,052.548,666.92
Contingent Liabilities1,969.15534.26152.93770.12,006.562,496.371,214.54427.41799.8558.92

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...4,379.99
Depreciation1,521.66
Interest (Net)-17.67
P/L on Sales of Assets-23.49
P/L on Sales of Invest-0.1
Prov. and W/O (Net)52.53
P/L in Forex-51.14
Total Adjustments (PBT and Ext...1,496.24
Operating Profit before Workin...5,876.23
Trade and 0ther Receivables-264.19
Inventories-1,303.68
Trade Payables582.84
Loans and Advances-0.69
Total Adjustments (OP before W...-1,675.07
Cash Generated from/(used in) ...4,201.16
Direct Taxes Paid-1,766.64
Total Adjustments(Cash Generat...-1,766.64
Cash Flow before Extraordinary...2,434.52
Net Cash from Operating Activi...2,434.52
Purchased of Fixed Assets-3,561.5
Sale of Fixed Assets60.28
Purchase of Investments-25.7
Sale of Investments179.15
Interest Received280.84
Net Cash used in Investing Act...-4,241.78
Proceed from 0ther Long Term B...1,563.24
Of the Long Tem Borrowings-17.17
Of the Short Term Borrowings-84.76
Of Financial Liabilities-146.6
Dividend Paid-263.64
Interest Paid-250.65
Net Cash used in Financing Act...800.42
Net Profit before Tax and Extr...2,475.41
Depreciation348.66
Interest (Net)-15.89
Dividend Received264.67
P/L on Sales of Assets-1.43
P/L on Sales of Invest30.07
Prov. and W/O (Net)11.11
P/L in Forex-38.11
Total Adjustments (PBT and Ext...69.61
Operating Profit before Workin...2,545.02
Trade and 0ther Receivables-743.59
Inventories-308.34
Trade Payables751.9
Loans and Advances-1.11
Total Adjustments (OP before W...-228.04
Cash Generated from/(used in) ...2,316.98
Direct Taxes Paid-602.18
Total Adjustments(Cash Generat...-602.18
Cash Flow before Extraordinary...1,714.8
Net Cash from Operating Activi...1,714.8
Purchased of Fixed Assets-426.75
Sale of Fixed Assets4.68
Purchase of Investments-3,932.05
Sale of Investments11.92
Interest Received199.51
Loans to Subsidiaires-2,345.35
Net Cash used in Investing Act...-151.58
Of the Short Term Borrowings-1,341.96
Of Financial Liabilities-21.71
Dividend Paid-263.64
Interest Paid-209.72
Net Cash used in Financing Act...-1,837.03

Company Details

Registered Office
AddressPlot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet
CityHyderabad
StateTelangana
Pin Code500038
Tel. No.91-40-23736370
Fax. No.91-40-23747340
Emailcs@aurobindo.com; investorgrievances@aurobindo.com
Internethttp://www.aurobindo.com
Registrars
AddressPlot No 2 Maitrivihar
CityHyderabad
StateTelangana
Pin Code500038
Tel. No.91-40-23736370
Fax. No.91-40-23747340
Emailcs@aurobindo.com; investorgrievances@aurobindo.com
Internethttp://www.aurobindo.com
Management
Name Designation
Kambam Nityananda ReddyVice Chairman & M.D.
M Madan Mohan ReddyWhole-time Director
P V Ramprasad ReddyNon Executive Director
Savita MahajanIndependent Director
Girish Paman VanvariIndependent Director
P Sarath Chandra ReddyNon Executive Director
Santanu MukherjeeIndependent Director
Deepali Pant JoshiIndependent Director
M R KumarChairman & Independent Directo
Satakarni MakkapatiNon Executive Director